| Dr Mathew Thomas Alexander, MD | |
|
1227 3rd St, Corpus Christi, TX 78404-2313 | |
| (361) 883-4323 | |
| (361) 883-4324 |
| Full Name | Dr Mathew Thomas Alexander |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 29 Years |
| Location | 1227 3rd St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174505887 | NPI | - | NPPES |
| 165317201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | L8590 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Corpus Christi Medical Center,the | Corpus christi, TX | Hospital |
| Christus Spohn Hospital Corpus Christi | Corpus christi, TX | Hospital |
| Christus Spohn Hospital Kleberg | Kingsville, TX | Hospital |
| Christus Spohn Hospital Beeville | Beeville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shea Physical Therapy Specialists Llc | 6204245194 | 106 |
| South Texas Brain And Spine Institute Pa | 6901973460 | 4 |
News Archive
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
Researchers discovered genetic evidence that human evolution is speeding up – and has not halted or proceeded at a constant rate, as had been thought – indicating that humans on different continents are becoming increasingly different.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Quest Diagnostics and Withings announced that the Withings WiFi Body Scale, the world's first WiFi connected personal weight scale, can now automatically import body weight data directly into Gazelle, the secure mobile health platform from Quest Diagnostics.
Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).
› Verified 9 days ago
| Entity Name | South Texas Brain & Spine Institute Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265607832 PECOS PAC ID: 6901973460 Enrollment ID: O20080924000741 |
News Archive
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
Researchers discovered genetic evidence that human evolution is speeding up – and has not halted or proceeded at a constant rate, as had been thought – indicating that humans on different continents are becoming increasingly different.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Quest Diagnostics and Withings announced that the Withings WiFi Body Scale, the world's first WiFi connected personal weight scale, can now automatically import body weight data directly into Gazelle, the secure mobile health platform from Quest Diagnostics.
Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mathew Thomas Alexander, MD 1227 3rd St, Corpus Christi, TX 78404-2313 Ph: (361) 883-4323 | Dr Mathew Thomas Alexander, MD 1227 3rd St, Corpus Christi, TX 78404-2313 Ph: (361) 883-4323 |
News Archive
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
Researchers discovered genetic evidence that human evolution is speeding up – and has not halted or proceeded at a constant rate, as had been thought – indicating that humans on different continents are becoming increasingly different.
Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Quest Diagnostics and Withings announced that the Withings WiFi Body Scale, the world's first WiFi connected personal weight scale, can now automatically import body weight data directly into Gazelle, the secure mobile health platform from Quest Diagnostics.
Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).
› Verified 9 days ago
Dr. Paul James Schmitt, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2606 Hospital Blvd Ste E, Corpus Christi, TX 78405 Phone: 361-902-4780 | |
Dr. Stefan J Konasiewicz, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1227 3rd St, Corpus Christi, TX 78404 Phone: 361-883-4323 Fax: 361-883-4324 | |
Dr. Ashley K Hanna, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3533 S Alameda St, Corpus Christi, TX 78411 Phone: 361-694-4700 | |
Patrick Langham Gleason, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1227 3rd St, Corpus Christi, TX 78404 Phone: 361-883-4323 Fax: 361-883-8216 |